Accipiter Life Sciences Fund, L.P. v. Helfer

905 A.2d 115, 2006 Del. Ch. LEXIS 140, 2006 WL 2589414
CourtCourt of Chancery of Delaware
DecidedAugust 2, 2006
DocketC.A. 2057-N
StatusPublished
Cited by8 cases

This text of 905 A.2d 115 (Accipiter Life Sciences Fund, L.P. v. Helfer) is published on Counsel Stack Legal Research, covering Court of Chancery of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Accipiter Life Sciences Fund, L.P. v. Helfer, 905 A.2d 115, 2006 Del. Ch. LEXIS 140, 2006 WL 2589414 (Del. Ct. App. 2006).

Opinion

*117 OPINION AND ORDER

LAMB, Vice Chancellor.

A corporation announced its annual stockholder’s meeting in a press release devoted mainly to financial results. A substantial stockholder failed to thoroughly read the document, failed to notice the stockholder meeting announcement, and thus failed to realize that, under the corporation’s advance notice bylaw, it had ten days from the date of that public announcement to nominate a slate of directors to the board. It discovered its mistake two months later when its then belated attempts to nominate candidates were rebuffed for tardiness. It then sued to overturn the results of the uncontested election.

The stockholder concedes that two of its employees read the document on the day it was released, that those employees would have understood the disclosure to require haste had they read the crucial paragraph, and that it could have met the ten-day deadline. Nevertheless, it seeks equitable relief setting aside the election, claiming that the company’s decision to place the announcement of the annual meeting in that particular press release constituted an inequitable manipulation of the corporation’s election machinery. Largely because the important annual meeting announcement was readily and easily available, the court rejects that argument and grants summary judgment in favor of the defendants.

I.

A. The Parties

Accipiter is a self-described hedge fund based in New York which focuses its investments on companies in the healthcare sector. It consists of five full-time employees, including the General Partner, Gabe Hoffman, and Nicole Viglucci, the senior analyst responsible for covering LifePoint Hospitals, Inc. Accipiter, either directly or through affiliates, purports to own approximately 1.4% of LifePoint’s shares.

LifePoint is a Delaware corporation engaged in providing healthcare services in rural communities. It was established on May 11, 1999, as a spin-off of HCA, Inc. The eight individual defendants comprise all of the members of LifePoint’s board of directors. One of these directors, Kenneth C. Donahey, is a member of management. The remaining seven directors are independent of the corporation.

B. The Facts

1. LifePoint’s Advance Notice Bylaw

LifePoint’s bylaws require that the board of directors set the date of the corporation’s annual stockholders meeting. In the past, the board has usually scheduled that meeting around the anniversary of LifePoint’s creation. Thus, LifePoint’s first four annual meetings were held on May 11, 2000, May 14, 2001, May 14, 2002, and May 21, 2003. That regular schedule was disrupted by various circumstances in both 2004 and 2005, when the meetings were held on June 15 and June 30, respectively. 1

The procedure that stockholders must follow if they wish to nominate candidates to the board of directors or to submit stockholder proposals is set forth in Section 11 of the corporation’s bylaws. Life-Point’s default rule is that a stockholder’s proposal or nomination of directors is timely if it is delivered to the corporation “not less than 90 days prior to the first anniversary of the preceding year’s annual *118 meeting of stockholders.” 2 On those occasions where the date of the annual meeting is advanced by more than 30 days from the previous year’s anniversary, or is delayed more than 60 days from that anniversary, however, a different rule applies. As set forth elsewhere in Section 11:

If the date of the annual meeting is advanced more than 30 days prior to or delayed more than 60 days after such anniversary date, notice by the stockholder to be timely must be delivered not later than close of business on the later of the 90th day prior to such annual meeting or the 10th day following the day on which public announcement of the date of such meeting is first made. 3

The bylaw further defines public announcement as “disclosure in a press release reported by the Dow Jones News Service, Associated Press or a comparable national news service or in a document publicly filed” with the SEC. 4

2. The 2006 Meeting Date

When the LifePoint board began compiling its calendar for 2006 and 2007 in the fall of 2005, the proposed date for the 2006 annual meeting was May 8, harking back to the early May annual meeting date of previous years. That initial plan was confirmed when, in mid-January 2006, Life-Point and its outside counsel prepared an annual meeting timeline that envisioned filing the company’s SEC Form 10-K by February 6, at the same time LifePoint would release its earnings for the fourth quarter and year-end of 2005. 5 The board was informally scheduled to approve the May meeting date, and the record date for the annual meeting, at a meeting on February 23, 2006. 6 Presumably, had that schedule been adhered to, the company would have announced its annual meeting shortly thereafter.

These plans changed when LifePoint received the first stockholder proposal in its history on January 12, 2006, submitted by Amalgamated Bank LongView MidCap 400 Index Fund. 7 The proposal was forwarded to the company’s outside legal counsel, Waller Lansden Dortch & Davis, which was in the process of preparing the proxy statement for the 2006 annual meeting. On February 1, 2006, an associate at the Waller firm suggested in an internal email that LifePoint should immediately announce its annual stockholder meeting date, which would trigger LifePoint’s advance notice bylaw, and require all further stockholder proposals to be submitted within 10 days of that announcement. 8 Later, a senior partner at the firm passed the associate’s suggestion to Bill Carpenter, the chief governance officer of Life-Point. 9

Carpenter was receptive to the idea. As he testified at his deposition, although he claimed that his goal was to “identify the universe of stockholder proposals that ... would have to be included in [LifePoint’s 2006 annual] proxy statement,” 10 his preference was to receive no additional stockholder proposals. 11 Therefore, he decided to authorize an addition to the earnings *119 press release due to be released on February 6 to announce the May 8 annual meeting. Carpenter forthrightly testified at his deposition that he could not remember making any special effort to determine whether such proposed action complied with Delaware law or SEC regulations, but rather concentrated on complying with the terns of the company’s bylaws. 12

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Coster v. UIP Companies, Inc.
Supreme Court of Delaware, 2023
Sternlicht v. Hernandez
Court of Chancery of Delaware, 2023
JANA Master Fund, Ltd. v. CNET Networks, Inc.
954 A.2d 335 (Court of Chancery of Delaware, 2008)
Portnoy v. Cryo-Cell International, Inc.
940 A.2d 43 (Court of Chancery of Delaware, 2008)
Openwave Systems Inc. v. Harbinger Capital Partners Master Fund I, Ltd.
924 A.2d 228 (Court of Chancery of Delaware, 2007)

Cite This Page — Counsel Stack

Bluebook (online)
905 A.2d 115, 2006 Del. Ch. LEXIS 140, 2006 WL 2589414, Counsel Stack Legal Research, https://law.counselstack.com/opinion/accipiter-life-sciences-fund-lp-v-helfer-delch-2006.